title: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications.
authors.affiliation: NYU Clinical Cancer Center , Rm 429, 160 East 34th Street, NY 10016 , USA franco.muggia@nyumc.org.
authors.forename: David
authors.initials: D
authors.lastname: Kudlowitz
authors.forename: Franco
authors.initials: F
authors.lastname: Muggia
mesh_terms: D000418:Albumins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D020258:Neurotoxicity Syndromes / Q000453:epidemiology / Q000209:etiology; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: C520255:130-nm albumin-bound paclitaxel; D000418:Albumins; D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel
keywords: NSCLC; breast cancer; nab-paclitaxel; ovarian cancer; paclitaxel; sensory neuropathy